FDA sees tamper-proof advantage in OxyContin version

09/22/2009 | Google

FDA scientists said a plasticlike coating for Purdue Pharma's painkiller OxyContin offers "limited" tamper-proof qualities, but that the version of the drug might "provide an advantage" over regular OxyContin. A panel of advisers will meet Thursday to review additional data on OxyContin.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA